Photo Rounds

Substantially enlarged cardiac silhouette

Author and Disclosure Information

 

References

Dx: Severe tricuspid valve regurgitation secondary to rheumatic heart disease

A transthoracic echocardiogram (FIGURE 2A) revealed cardiomegaly with massive right atrial enlargement; a color-flow Doppler (FIGURE 2B) revealed severe tricuspid regurgitation, reduced right ventricular systolic function, and preserved left ventricular systolic function. All of these findings pointed to the diagnosis of rheumatic heart disease (RHD), especially in the context of prior mitral valve stenosis.

Additional imaging confirmed  the diagnosis

RHD affects more than 33 million people annually and remains a significant problem globally.1 It’s associated with a relatively poor prognosis, especially if heart failure is present (as it was in this case).2,3 Although the mitral and aortic valves are most commonly affected, approximately 34% of patients will develop tricuspid regurgitation.4 Right-side cardiac manifestations of RHD may lead to clinical heart failure with chronic venous congestion and, ultimately, cirrhosis.

Suspect RHD when encountering a new murmur in a patient with prior history of acute rheumatic fever, especially if they are living in or are from a country where rheumatic disease is endemic (most of the developing world).

The diagnosis is confirmed when echocardiographic findings demonstrate characteristic pathologic valve changes (eg, thickening of the anterior mitral valve leaflet, especially the leaflet tips and subvalvular apparatus).

The differential for an enlarged cardiac silhouette

The differential diagnosis for an enlarged cardiac silhouette on CXR includes cardiomegaly (as in this case), pericardial effusion, or a thoracic mass (either mediastinal or pericardial). Imaging artifact from patient orientation may also yield the appearance of an enlarged cardiac silhouette. Distinguishing between these entities may be accomplished by incorporating the history with selection of more definitive imaging (eg, echocardiogram or computed tomography).

Continue to: Management depends on the severity and symptoms

Recommended Reading

FDA okays difelikefalin for dialysis-associated pruritus in patients with CKD
Clinician Reviews
FIDELITY: Finerenone benefits patients with T2D across CKD spectrum
Clinician Reviews
What are the cardiorenal differences between type 1 and type 2 diabetes?
Clinician Reviews
SGLT2 inhibitors for diabetes: No link to fractures in older adults
Clinician Reviews
Finerenone, sotagliflozin exert heart failure benefits despite renal dysfunction
Clinician Reviews
HIV+ patients get good outcomes after kidney or liver transplant
Clinician Reviews
Allopurinol found safe in patients with concomitant gout, CKD
Clinician Reviews
No COVID vax, no transplant: Unfair or good medicine?
Clinician Reviews
Biomarkers predict cardiovascular risk in chronic kidney disease patients
Clinician Reviews
Lowering BP according to newest guidance would cut CV events
Clinician Reviews